IMPLICIT BIOSCIENCE

We are a private company, with a noble investment proposition, welcoming support from philanthropists, private investors and government sources... IC14 regulates pathogenic inflammatory responses to infection and injury, and has great potential across a variety of disease areas. Right now, we are focused on testing its efficacy in the fight against Motor Neurone Disease (MND) or Amyotrophic lateral sclerosis (ALS), and Coronavirus (COVID-19).

Primary location: Seattle United States